📄
paper

Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition.

📄 Paper Details
Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition.
Chapman IG, Wu X, Veuger S, Jowsey PA
PLoS One PubMed DOI
Abstract

Microcephalin-1 (MCPH1) is a tumour suppressor protein that regulates homologous recombination repair (HRR) and is down-regulated in several tumour types. Given that HRR-defective cancer cells can be killed via synthetic lethal approaches, MCPH1 thus represents an attractive target in cancer therapy. Functionally, cells lacking MCPH1 have reported defects in the recruitment and retention of BRCA2 and RAD51 to DNA double strand breaks (DSBs) during HRR, though the magnitude of this defect in huma...

View on SciDEX ↗